Emerging cytoprotective peptide therapies for stroke

Bruno P Meloni^{1

2

3}, David J Blacker^{1

2

4}, Frank L Mastaglia^{1

2}, Neville W Knuckey^{1

2

3}

Affiliations

¹ Perron Institute for Neurological and Translational Science , Nedlands, Australia.
² Department of Neurosurgery, Sir Charles Gairdner Hospital, QEII Medical Centre , Nedlands, Western Australia, Australia.
³ Centre for Neuromuscular and Neurological Disorders, The University of Western Australia , Nedlands, Western Australia, Australia.
⁴ Department of Neurology, Sir Charles Gairdner Hospital, QEII Medical Centre , Nedlands, Western Australia, Australia.

Editorial

Bruno P Meloni et al. Expert Rev Neurother. 2020 Sep.

. 2020 Sep;20(9):887-890.

doi: 10.1080/14737175.2020.1788390. Epub 2020 Aug 19.

Bruno P Meloni^{1

2

3}, David J Blacker^{1

2

4}, Frank L Mastaglia^{1

2}, Neville W Knuckey^{1

2

3}

¹ Perron Institute for Neurological and Translational Science , Nedlands, Australia.
² Department of Neurosurgery, Sir Charles Gairdner Hospital, QEII Medical Centre , Nedlands, Western Australia, Australia.
³ Centre for Neuromuscular and Neurological Disorders, The University of Western Australia , Nedlands, Western Australia, Australia.
⁴ Department of Neurology, Sir Charles Gairdner Hospital, QEII Medical Centre , Nedlands, Western Australia, Australia.

No abstract available

Keywords: CN-105; NA-1; R18; Stroke; cationic arginine-rich peptides (CARPs); neuroprotection.

Publication types